Literature DB >> 1400416

Primary structure of Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase determined by mass spectrometry sequence analysis and molecular cloning. Evidence for a protein motif in the sialyltransferase gene family.

D X Wen1, B D Livingston, K F Medzihradszky, S Kelm, A L Burlingame, J C Paulson.   

Abstract

The Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase forms the NeuAc alpha 2,3Gal beta 1,3(4)GlcNAc sequences found in terminal carbohydrate groups of glycoproteins and glycolipids. High energy collision-induced dissociation analysis of tryptic peptides from only 300 pmol of the purified Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase provided 25% of the total amino acid sequence and led to the successful cloning of this enzyme. The peptide sequence information was used to design short degenerate primers for use in the polymerase chain reaction. A long specific cDNA fragment was amplified which was used to isolate a clone from a rat liver cDNA library. The cloned cDNA encodes a 374-amino acid protein containing an amino-terminal signal-anchor sequence characteristic of all cloned glycosyltransferases and produced sialyltransferase activity when transiently expressed in COS-1 cells. When compared with two other cloned sialyltransferases, the primary structure of Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase revealed a homologous region in all three enzymes consisting of a stretch of 55 amino acids located in their catalytic domains. This feature together with lack of homology in the remaining 85% of the sequence of the three sialyltransferases defines a pattern of sequence homology not found in cloned cDNAs of other glycosyltransferase families.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400416

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

Review 2.  Lessons in de novo peptide sequencing by tandem mass spectrometry.

Authors:  Katalin F Medzihradszky; Robert J Chalkley
Journal:  Mass Spectrom Rev       Date:  2015 Jan-Feb       Impact factor: 10.946

3.  Glycan microarrays for screening sialyltransferase specificities.

Authors:  Ola Blixt; Kirk Allin; Ognian Bohorov; Xiaofei Liu; Hillevi Andersson-Sand; Julia Hoffmann; Nahid Razi
Journal:  Glycoconj J       Date:  2007-10-04       Impact factor: 2.916

4.  Search of sequence databases with uninterpreted high-energy collision-induced dissociation spectra of peptides.

Authors:  J R Yates; J K Eng; K R Clauser; A L Burlingame
Journal:  J Am Soc Mass Spectrom       Date:  1996-11       Impact factor: 3.109

Review 5.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

6.  Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression.

Authors:  H G Augustin; K Braun; I Telemenakis; U Modlich; W Kuhn
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

7.  Identification of the gonococcal glmU gene encoding the enzyme N-acetylglucosamine 1-phosphate uridyltransferase involved in the synthesis of UDP-GlcNAc.

Authors:  J Ullrich; J P van Putten
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

8.  Different sialyltransferase activities in human colorectal carcinoma cells from surgical specimens detected by specific glycoprotein and glycolipid acceptors.

Authors:  W Kemmner; D Krück; P Schlag
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

9.  Identification and analysis of novel functional sites in human GD3-synthase.

Authors:  Yihua Gu; Robert K Yu
Journal:  Biochem Biophys Res Commun       Date:  2008-03-17       Impact factor: 3.575

10.  alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.

Authors:  Marta Pérez-Garay; Beatriz Arteta; Lluís Pagès; Rafael de Llorens; Carme de Bolòs; Fernando Vidal-Vanaclocha; Rosa Peracaula
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.